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Abstract
Objective To evaluate the primary diagnoses and patterns of 30 day
readmissions and potentially avoidable readmissions in medical patients
with each of the most common comorbidities.
Design Retrospective cohort study.
Setting Academic tertiary medical centre in Boston, 2009-10.
Participants 10 731 consecutive adult discharges from a medical
department.
Main outcome measures Primary readmission diagnoses of
readmissions within 30 days of discharge and potentially avoidable 30
day readmissions to the index hospital or two other hospitals in its
network.
Results Among 10 731 discharges, 2398 (22.3%) were followed by a
30 day readmission, of which 858 (8.0%) were identified as potentially
avoidable. Overall, infection, neoplasm, heart failure, gastrointestinal
disorder, and liver disorder were the most frequent primary diagnoses
of potentially avoidable readmissions. Almost all of the top five diagnoses
of potentially avoidable readmissions for each comorbidity were possible
direct or indirect complications of that comorbidity. In patients with a
comorbidity of heart failure, diabetes, ischemic heart disease, atrial
fibrillation, or chronic kidney disease, the most common diagnosis of
potentially avoidable readmission was acute heart failure. Patients with
neoplasm, heart failure, and chronic kidney disease had a higher risk of
potentially avoidable readmissions than did those without those
comorbidities.
Conclusions The five most common primary diagnoses of potentially
avoidable readmissions were usually possible complications of an
underlying comorbidity. Post-discharge care should focus attention not
just on the primary index admission diagnosis but also on the
comorbidities patients have.
Introduction
Preventable readmissions to hospital are frequent, costly, and
demanding on healthcare resources; they also represent threats
to patients’ safety such as preventable adverse drug events,
healthcare associated infections, procedural complications, and
avoidable exacerbations in disease states or functional declines.
The recent focus on readmissions in some countries, including
the United States, Germany, Switzerland, and England, driven
in part by their effects on costs, thus underlies a much more
global concern about patients’ safety.
Hospital readmission represents a multifaceted problem that
still needs to be better understood. Evidence shows that
readmission diagnoses usually differ from the specific acute
diagnosis responsible for the index hospital admission.1 2 On
the other hand, higher comorbidity has been shown to be
associated with an increased risk of readmission.3-5 Also, in a
recent study, most of the 30 day readmissions after pneumonia
were found to be comorbidity related.6 Thus, the role of
comorbidities in causing readmissions is complex, but relatively
few studies have looked at this. The subject will take on greater
importance as a growing percentage of the world’s population
becomes older and the incidence of comorbidities rises.
A better understanding of the causes and patterns of
readmissions in patients with common comorbidities may lead
to more targeted and successful interventions, and these
strategies may differ by condition. In addition, few data are
available regarding to what extent the causes and patterns of all
cause readmissions differ from the readmissions that are
avoidable and thus actionable. We hypothesized that patients’
comorbidities have an important role in the primary diagnosis
of 30 day potentially avoidable readmission and that
preventability of readmissions may vary among patients with
different comorbidities. Therefore, our aim was to evaluate the
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primary diagnoses and patterns of 30 day readmissions and
potentially avoidable readmissions according to the most
common comorbidities in medical patients.
Methods
Study design and population
We included all consecutive discharges of adult patients from
any medical service of the Brigham and Women’s Hospital
between July 1 2009 and June 30 2010. We included only
discharges following a length of stay of more than 24 hours to
avoid inclusion of stays for observation. Brigham andWomen’s
Hospital is a 750 bed academic medical center in Boston,
Massachusetts, with the following medical services: general
medicine, cardiology, oncology, bone marrow transplant,
endocrinology, gastroenterology, hematology, infectious
diseases, rheumatology, and nephrology. Exclusion criteria were
death before discharge, transfer to another acute healthcare
facility, and discharge against medical advice.
Study outcome
The outcome of the study was any readmission within 30 days
of discharge to any service of three hospitals within the Partners
network in Boston, including Brigham and Women’s Hospital,
Massachusetts General Hospital (a 1000 bed tertiary care
hospital), and Faulkner Hospital (a 150 bed community hospital
closely affiliated with Brigham and Women’s Hospital). More
than 80% of all readmissions after an index medical admission
to Brigham and Women’s Hospital are captured in this
network.7 8 We used a validated algorithm (SQLape) to identify
among these readmissions the ones that were deemed potentially
avoidable.9 10 This algorithm uses diagnostic and procedure
codes of both index admission and readmission to differentiate
potentially avoidable readmissions from unavoidable
readmissions. More precisely, it excludes as unavoidable
foreseen readmissions such as readmissions for transplantation,
labor and delivery, chemotherapy or radiotherapy, and other
specific surgical procedures. Follow-up and rehabilitation
treatments are also considered unavoidable. Readmissions for
a disease in a new system (for example, circulatory, respiratory,
digestive, hepatic, nervous, blood) unknown to be affected
during the preceding stay are also considered unavoidable. Also,
readmissions due to some specific diseases deemed difficult to
cure (such as multiple sclerosis and idiopathic
thrombocytopenia) are considered unavoidable. Conversely,
complications of treatment (for example, deep vein thrombosis,
catheter associated urinary tract infection, drug induced
disorders) are considered potentially avoidable, as are
readmissions for conditions related to those present during the
index admission (web appendix). The sensitivity and specificity
of the screening algorithm both reached 96% when compared
with medical chart review (using the same criteria) in a random
sample of admission-readmission pairs.11 To exclude the
possibility that administrative data contained incomplete
information on the elective status of a readmission, nine senior
medical residents excluded any readmissions deemed to be
planned on the basis of the discharge summaries of both the
index admission and readmission. These residents received one
hour of training in how to perform this task, including review
of several standardized cases.
Comorbidities
We retrieved the most frequent comorbidities by using the
following ICD-9-CM (international classification of diseases,
9th edition, clinical modification) codes from the index
admission: diabetes mellitus (249.00-250.99), congestive heart
failure (428.x, 425.4-425.9, 402.01, 402.11, and 398.91),
ischemic cardiac disease (410.00-414.99), atrial
flutter/fibrillation (427.30-427.32), chronic obstructive
pulmonary disease (491.00-492.99, 493.2, and 496), chronic
kidney disease (585.00-586.99), and neoplasm (140.00-239.99).
Primary readmission diagnoses
We then identified the 13 most frequent primary diagnoses that
occurred in the entire cohort, both for all readmissions and for
potentially avoidable readmissions. The following diagnoses
were retained using Medicare Severity-Diagnosis Related
Groups (MS-DRG) codes from the readmission: heart failure
(291-293, 189), chronic obstructive pulmonary disease
(190-192), cardiac ischemic disease (231-236, 246-251,
280-285), arrhythmia (308-310), cerebrovascular diseases
(061-072), adverse drug events (917-923), renal failure
(682-685), nutritional andmetabolic disorders (640-641), venous
thromboembolism (175-176, 294-295), liver disorders (405-434,
438-446), gastrointestinal disorders (391-392, 377-384),
infectious diseases (075-076, 094-099, 121-122, 177-179,
193-195, 371-373, 485-489, 548-550, 689-690, 757-759,
853-863, 865-872), and neoplasm (054-055, 146-148, 180-182,
374-376, 435-437, 582-583, 597-599, 656-658, 686-688,
715-724, 736-741, 754-756, 846-849). We defined primary
diagnoses for the index admissions in the same way. We chose
MS-DRG codes for this purpose because they more closely
correlate with the reason for the hospital admission than do
ICD-9 CM codes.
Statistical analysis
We present patients’ baseline characteristics as proportions,
means with standard deviations, or medians with interquartile
ranges as appropriate. The unit of analysis was any patient’s
index discharge from a medical service. To evaluate the
importance of each comorbidity on the causes of readmissions,
we identified the proportion of the five most common primary
readmission diagnoses for each comorbidity for both all cause
30 day readmissions and potentially avoidable 30 day
readmissions.
To further assess whether the primary readmission diagnosis
was related to the primary diagnosis at index admission or to a
comorbidity, we examined patients readmitted for a diagnosis
closely related to a comorbidity (for example, readmission for
acute heart failure exacerbation in a patient with a comorbidity
of chronic heart failure) and then determined the proportion for
whom that was also the primary diagnosis of the index admission
(that is, whether or not acute heart failure was also the primary
admission diagnosis for the index admission).
Next, to evaluate whether patients with a specific comorbidity
were at higher risk of potentially avoidable readmission (versus
no readmission), we calculated the crude and adjusted relative
risk with 95% confidence interval of avoidable readmission
between patients with versus without each comorbidity. We
then usedmultivariable logistic regression with all comorbidities
in the model, adjusted for the following potential confounders
of potentially avoidable readmission: length of stay of index
admission, mode of admission (elective or not), number of
admissions in the previous 12 months, number of procedures
during the index admission, and hemoglobin and sodium
concentrations at the time of discharge of the index admission.12
We used generalized estimating equations to account for
clustering due to repeated admissions of the same patient.13
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We also calculated the crude and adjusted relative risks (the
adjusted relative risks were calculated as ratios of adjusted
probabilities from the logistic regression models) to evaluate
whether patients with each of the comorbidities had a higher
proportion of readmissions deemed potentially avoidable (versus
unavoidable) compared with those without each comorbidity.
For these models, we used the same covariates as in the previous
analyses.
We evaluated all tests as two sided at a 0.05 level of
significance. We used SAS software, version 9.3 for analyses.
Results
A total of 12 383 patients were discharged from the medical
services of the Brigham andWomen’s Hospital during the study
period (fig 1⇓). After exclusion of deaths before discharge
(n=363), transfers to another acute healthcare facility (n=1217),
and discharges against medical advice (n=72), 10 731 discharges
remained for analysis. Of these, 22.3% (n=2398) were followed
by a 30 day readmission, of which 858 (8.0% of all admissions,
35.8% of readmissions) were identified as potentially avoidable.
Table 1⇓ shows baseline characteristics. The mean age in the
entire cohort was 61.0 (SD 16.7) years at inclusion, and about
half were male. The mean number of selected comorbidities for
each patient’s discharge was 1.74 (SD 1.22).
Primary diagnoses for all cause and
potentially avoidable readmissions
Overall, the most common primary diagnoses of 30 day
readmissions in the entire cohort were neoplasm (16.8%; n=402),
infection (10.9%; n=260), heart failure (4.9%; n=116), liver
disorders (4.4%; n=105), and gastrointestinal disorders (3.6%;
n=86) (table 2⇓). After we restricted the analyses to the
potentially avoidable readmissions only, the three most common
primary readmission diagnoses were infection (11.6%; n=99),
neoplasm (8.4%; n=72), and heart failure (7.1%, n=61) (table
3⇓). The most frequent avoidable readmission diagnoses of
infection were pneumonia and respiratory infection (30.7%;
31/99), septicemia (29.7%; 30/99), and kidney or urinary tract
infection (20.8%; 21/99).
Primary diagnoses of potentially avoidable
readmission by comorbidity
Heart failure and infection were the two most common
readmission diagnoses for patients with most of the chronic
comorbidities, accounting together for 21.6% to 34.3% of all
avoidable readmissions (table 3⇓). Only the patients with
neoplasm did not have heart failure as one of the five most
common primary readmission diagnoses. Heart failure was,
however, the single most common primary diagnosis of
avoidable readmission in patients with five of the seven studied
comorbidities: chronic heart failure, ischemic heart disease,
atrial fibrillation, diabetes mellitus, and chronic kidney disease
(and was essentially tied for the most common diagnosis in
patients with chronic obstructive pulmonary disease). Of note,
92% (110/120) of the patients with ischemic heart disease, atrial
fibrillation, diabetes, and kidney disease readmitted for heart
failure had a known comorbidity of chronic heart failure during
the index admission. Other frequent primary diagnoses of
avoidable readmissions in patients with comorbidities were
neoplasm, ischemic heart disease, arrhythmia, renal failure, liver
disorders, and gastrointestinal disorders.
Relation of potentially avoidable readmission
diagnoses to comorbidities
The top five primary diagnoses of potentially avoidable
readmissions (table 3⇓) were almost all known or at least
possible complications of each comorbidity. For example,
patients with neoplasm were most frequently readmitted for
care of their neoplasm or potentially related complications such
as infection (for example, from immunosuppressive
chemotherapy), metabolic disorder (for example, from cancer
related syndrome of inappropriate antidiuretic hormone or
therapy induced dehydration), gastrointestinal disorder (for
example, from therapy related nausea, vomiting, or diarrhea),
or renal failure (for example, from therapy induced dehydration
and pre-renal azotemia or directly toxic effects of
chemotherapy).
Our analyses to explore the relation between index admission
diagnoses and comorbidities as the causes of readmission further
emphasized the importance of comorbidities. For example, when
patients with a comorbidity of chronic heart failure had a 30
day potentially avoidable readmission due to an acute heart
failure exacerbation, in half of the cases (50%; 27/54) the
patients had a different primary diagnosis during the index
admission (fig 2⇓). Similarly, in cases of atrial fibrillation,
ischemic heart disease, chronic kidney disease, and neoplasm,
55-80% of patients who were readmitted for an acute episode
of their underlying chronic comorbidity had a different primary
diagnosis at the index admission.
Comorbidities and risk of potentially
avoidable readmission
Patients with cancer had an almost twofold increase in adjusted
risk of potentially avoidable readmission in comparison with
patients without cancer (table 4⇓). However, when readmitted,
patients with cancer had a similar adjusted risk of readmissions
deemed potentially avoidable (versus unavoidable) to those
without cancer (table 5⇓). Patients discharged with a diagnosis
of chronic heart failure had a significant 23% increased adjusted
risk of having a potentially avoidable readmission (table 4⇓).
Readmissions among patients with chronic heart failure had a
non-significant 9% higher adjusted risk of being potentially
avoidable in comparison with patients without chronic heart
failure (table 5⇓). Patients with chronic kidney disease had not
only a significantly higher risk of being deemed potentially
avoidable readmission (table 4⇓) but also a significantly higher
proportion of readmissions deemed potentially avoidable than
in those without the disease (table 5⇓). For patients with the
other comorbidities (diabetes mellitus, ischemic heart disease,
atrial fibrillation, and chronic obstructive pulmonary disease),
we found no statistically significant differences in adjusted risk
of avoidable readmission or in the proportion of readmissions
deemed potentially avoidable compared with patients without
those diseases.
Discussion
In this medical cohort, we found that the five most frequent
primary diagnoses of readmission were often related, either
directly or indirectly, to patients’ specific comorbidities. Also,
although infection was the most frequent cause of potentially
avoidable readmission overall, acute heart failure was the most
frequent cause of potentially avoidable readmission among
patients with five of the seven comorbidities we studied,
especially the cardiovascular ones. In patients readmitted for a
primary diagnosis that was related to a comorbidity (for
example, acute heart failure exacerbation in a patient with
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chronic heart failure), the patients were more often than not
discharged from the index hospital admission with a different
primary diagnosis. These findings do not negate the role of the
primary diagnosis of the index admission in transitional care,
but they do underscore the importance of patients’ underlying
comorbidities in explaining the primary causes of 30 day
potentially avoidable readmissions.
Comparison with other studies
The study is innovative, as it provides insight regarding
readmission diagnoses in patients with each of the most frequent
comorbidities, instead of restricting the analysis to the primary
diagnosis of the index admission. It also differentiates
unavoidable from potentially avoidable readmissions and gives
adjusted measures of risk. It extends the findings of two major
studies that looked at causes of readmission on the basis of the
primary diagnosis of the index admission.1 2 These studies found
that most of the causes of readmission were different from the
specific first diagnosis of the index admission, suggesting the
importance of underlying comorbidities. It is therefore
interesting to see here that almost all of the top five primary
diagnoses of potentially avoidable readmission found for each
comorbidity are possible direct or indirect complications of that
comorbidity. Besides the neoplasm example provided in the
results section, in patients with chronic obstructive pulmonary
disease, for example, infections, chronic obstructive pulmonary
disease exacerbations, and (right) heart failure are direct
complications,14-17 whereas neoplasm and venous
thromboembolismmay be explained by shared risk factors such
as smoking.18-20
One appealing explanation for these results is that the acute
condition responsible for the index admission weakens the
overall health of the patient and induces a higher risk of
complications or exacerbations related to the (previously) stable
comorbidity. The post-discharge period is a fragile period, which
has been referred to as “post-hospital syndrome.”21 This
syndrome has been described as a period of vulnerability due
to impaired physiological systems, depleted reserves, and lower
body resistance against health threats, on top of the acute illness
responsible for the index admission. Our study results bring
another dimension to this theory: that comorbidities of patients
also play a significant role in the post-discharge period. They
might be well exacerbated by the acute illness and the stress of
the index admission, and may consequently lead to new acute
illnesses that increase the risk of readmission. In addition,
changes made to chronic drug treatment in the hospital and after
discharge may cause loss of disease control or adverse drug
events, which represent a large proportion of all post-discharge
adverse events.22 Lastly, diversion of attention from chronic
comorbidities to the acute illness may also play a role, leading,
for example, to insufficient monitoring after discharge.
As much of the existing literature on readmissions focuses on
heart failure, it is worth noting that readmissions were most
often due to infections in this study. This important finding
should reinforce our efforts to better understand the processes
that lead to readmissions for infectious diseases and how they
can bemonitored and prevented. This cause of readmission was
not listed as a primary diagnosis of readmission in previous
studies, as they looked at subcategories of infectious diseases
such as pneumonia, urinary tract infection, and septicemia
instead of considering them as one category. We chose to
combine them, as the clinical actions to be taken (for example,
post-discharge surveillance for signs or symptoms of worsening
infection) are similar for all of them (as opposed to the various
heart diseases, for which the potential actions to be taken are
likely to be different).
The percentage of readmissions deemed potentially avoidable
was similar to that found in a previous literature review.23 We
found three comorbidities associated with higher adjusted risk
for potentially avoidable readmission: neoplasm, heart failure,
and chronic renal failure. What all three have in common is a
set of complications that lead to readmission and are somewhat
predictable and amendable to monitoring, with the potential to
take action before readmission is needed, at least in some
patients. Patients with chronic kidney disease, when readmitted,
were also more likely to have their readmissions deemed
potentially avoidable.24
Limitations of study
This study has several limitations. Firstly, it is a single centre
study in a tertiary care hospital. The case mix of patients
discharged from the study hospital may differ from that of other
hospitals, so the results may not be generalizable to other
hospitals, especially to community hospitals, although it is likely
similar to other academic medical centers in the United States
and elsewhere. However, Brigham and Women’s Hospital is
associated with the Dana-Farber Cancer Institute, which might
increase the number of complex cancer patients in our cohort
(and therefore the risk of avoidable readmission in these
patients). Regarding standards for transitional care at Brigham
andWomen’s Hospital, preliminary results from a benchmarking
study of 13 hospitals indicate that Brigham and Women’s
Hospital is similar to other hospitals in terms of degree of
communication with primary care physicians, time to follow-up,
and use of care coordination and may have better systems in
place for discharge documentation.25
Secondly, we cannot prove that the estimated 20% of patients
readmitted outside the Partners network have similar patterns
of readmission. One might expect, for example, two opposing
forces: patients might preferentially return to Brigham and
Women’s Hospital with a complication related to their primary
diagnosis from the index admission but also be more likely to
return to Brigham and Women’s Hospital if they have a
specialist there who cares for one of their comorbidities.
Thirdly, the differentiation between potentially avoidable and
unavoidable readmissions cannot be perfect. A recent systematic
review showed important variations in the definition of
preventability among different studies and adjudicators.23
Nevertheless, although SQLape may have false negatives,
mainly due to complications that are not coded in the
readmission, it does have the advantages of using clear and
clinically logical criteria, being very reproducible, and allowing
for large data analysis. Other definitions of preventable
readmissions (such as those of the US Agency for Healthcare
Research and Quality, which uses ambulatory care sensitive
conditions, or the US Centers for Medicare and Medicaid
Services, which uses an algorithm to exclude planned
readmissions) might produce different results, but no inherent
reason exists to believe that these would be more valid than
those presented here.
Fourthly, we were not able to adjust the analysis for functional
status or other factors such as appropriateness of drugs, clinical
stability at discharge, or social networks that might influence
readmission. We cannot exclude the possibility of residual
confounding in our models. The extent to which these would
affect the causes of potentially avoidable readmission, as
opposed to absolute risk of potentially avoidable readmission,
is a matter of debate.
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Fifthly, we were not able to assess the severity of each
comorbidity. One may argue that the primary readmission
diagnosis depends on the severity of each comorbidity.
Sixthly, although we have provided examples of how each
primary diagnosis at readmission could be related to each
chronic comorbidity, and although these relations are likely,
some diagnoses may not in fact be related (for example,
gastrointestinal diseases not caused by cancer chemotherapy in
a patient with cancer).
Finally, owing to the many stratifications between each
comorbidity and the readmission diagnoses, we may have had
insufficient power to detect smaller differences in the
preventability of readmissions by comorbidity.
Implications
This study has several implications. Transitions of care should
focus not only on the acute condition responsible for the index
admission but also on patients’ underlying comorbidities that
may increase the risk of new, acute complications. Interventions
could include close follow-up and monitoring of patients’
comorbidities in the post-discharge period.More attention could
be paid in particular to patients with neoplasm, heart failure,
and chronic renal failure who are at higher risk of potentially
avoidable readmission than are patients without these conditions.
Heart failure in particular should be a focus (for example, with
close monitoring of weights and renal function) in patients who
have the condition, regardless of the other heart conditions with
which it frequently coexists. Lastly, further work is needed to
explore the nature of infections causing potentially avoidable
readmission and to identify possible ways in which they could
be avoided in the future.
Conclusions
By providing a description of primary diagnoses and patterns
of readmissions for patients with common comorbidities, our
study supports the need for post-discharge care to focus attention
not just on the primary index hospital admission diagnosis but
also on the underlying comorbidities that may cause acute new
complications that lead to readmission.
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What is already known on this topic
Evidence shows that readmission diagnoses usually differ from the specific acute diagnosis responsible for the index hospital admission
Higher comorbidity has been shown to be associated with an increased risk of readmission, but little is known about the effect of the
most common specific comorbidities on the causes of readmissions
Although the causes of readmission in general have been identified, few data are available regarding to what extent the causes of all
readmissions differ from the causes of avoidable ones
What this study adds
In patients with common comorbidities, the five most common primary diagnoses of potentially avoidable readmissions were possible
complications of each underlying comorbidity
In many cases, these principal diagnoses were unrelated to those of the index admission
Post-discharge care should focus attention not just on the cause of the index admission but also on the comorbidities patients have
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Tables
Table 1| Baseline characteristics
Unavoidable readmissions
(n=1540)
Potentially avoidable
readmissions (n=858)All readmissions (n=2398)Entire cohort (n=10 731)Characteristic
59.2 (16.4)60.7 (16.4)59.7 (16.4)61.0 (16.7)Mean (SD) age, years
799 (51.9)409 (47.7)1208 (50.4)5265 (49.1)No (%) male sex
Ethnicity—No (%):
1184 (76.9)630 (73.4)1814 (75.7)7821 (72.9)Non-Hispanic white
233 (15.1)136 (15.9)369 (15.4)1729 (16.1)Non-Hispanic black
96 (6.2)77 (9.0)173 (7.2)868 (8.1)Hispanic
27 (1.8)15 (1.8)42 (1.8)313 (2.9)Other
Language—No (%):
1434 (93.1)787 (91.7)2221 (92.6)9790 (91.2)English
53 (3.4)49 (5.7)102 (4.3)534 (5.0)Spanish
53 (3.4)22 (2.6)75 (3.1)407 (3.8)Other
Marital status—No (%):
818 (53.1)440 (51.3)1258 (52.5)5504 (51.3)Currently married or partner
405 (26.3)216 (25.2)621 (25.9)2714 (25.3)Single/never married
317 (20.6)202 (23.5)519 (21.6)2513 (23.4)Separated/divorced/ widowed/no answer
Primary insurance—No (%):
705 (45.8)430 (50.1)1135 (47.3)5374 (50.1)Medicare
138 (9.0)77 (9.0)215 (9.0)885 (8.3)Medicaid
690 (44.8)348 (40.6)1038 (43.3)4453 (41.5)Private
7 (0.5)3 (0.4)10 (0.4)19 (0.2)No insurance
Type of index admission—No (%):
321 (20.8)80 (9.3)401 (16.7)1502 (14.0)Elective
1219 (79.2)778 (90.7)1997 (83.3)9229 (86.0)Urgent or emergent
4.5 (3-8)5 (3-8)5 (3-8)4 (3-7)Median (IRQ) length of stay of index
admission, days
1 (0-3)1 (0-3)1 (0-3)1 (0-2)Median (IRQ) No of hospital admissions in
previous year
1.80 (1.11)2.05 (1.25)1.89 (1.17)1.74 (1.22)Mean (SD) No of selected chronic diseases
Selected comorbidities—No (%):
900 (58.4)441 (51.4)1341 (55.9)4129 (38.5)Neoplasm
331 (21.5)238 (27.7)569 (23.7)2639 (24.6)Diabetes mellitus
279 (18.1)209 (24.4)488 (20.4)2308 (21.5)Chronic heart failure
326 (21.2)211 (24.6)537 (22.4)2823 (26.3)Ischemic heart disease
200 (13.0)134 (15.6)334 (13.9)1832 (17.1)Atrial fibrillation
144 (9.4)87 (10.1)231 (9.6)1078 (10.0)Chronic obstructive pulmonary disease
226 (14.7)184 (21.5)410 (17.1)1776 (16.6)Chronic kidney disease
IRQ= interquartile range.
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Table 2| Most frequent primary diagnoses of all 30 day readmissions among patients with common comorbidities
Five most likely primary readmission diagnoses
Comorbidity FifthFourthThirdSecondFirst
Metabolic disorder (2.1%;
n=28)
Liver disorder (2.3%;
n=31)
Gastrointestinal disorder
(3.1%; n=41)
Infection (11.1%; n=149)Neoplasm (29.6%;
n=397)
Neoplasm (n=1341)
Gastrointestinal disorder
(4.4%; n=25)
Liver disorder (5.0%;
n=28)
Neoplasm (8.2%; n=46)Heart failure (10.3%;
n=58)
Infection (10.7%; n=60)Diabetes mellitus
(n=563)
Arrhythmia (3.3%; n=16)Neoplasm (4.6%; n=22)Ischemic heart disease
(5.8%; n=28)
Infection (10.1%; n=49)Heart failure (21.5%;
n=104)
Chronic heart failure
(n=483)
Gastrointestinal disorder
(3.8%; n=20)
Neoplasm (6.9%; n=37)Ischemic heart disease
(8.3%; n=44)
Heart failure (10.5%;
n=56)
Infection (10.9%; n=58)Ischemic heart disease
(n=533)
Neoplasm (5.1%; n=17)Arrhythmia (6.6%; n=22)Ischemic heart disease
(6.9%; n=23)
Infection (12.7%; n=42)Heart failure (13.9%;
n=46)
Atrial fibrillation (n=332)
Arrhythmia (3.9%; n=9)COPD (7.0%; n=16)Heart failure (11.4%; n=26)Neoplasm (12.7%; n=29)Infection (13.1%; n=30)COPD (n=229)
Gastrointestinal disorder
(4.4%; n=18)
Ischemic heart disease
(4.4%; n=18)
Renal failure (5.4%; n=22)Infection (8.8%; n=36)Heart failure (15.2%;
n=62)
Chronic kidney disease
(n=408)
Gastrointestinal disorder
(3.6%; n=86)
Liver disorder (4.4%;
n=105)
Heart failure (4.9%; n=116)Infection (10.9%; n=260)Neoplasm (16.8%;
n=402)
Entire cohort (n=2387)
COPD=chronic obstructive pulmonary disease.
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Table 3| Most frequent primary diagnoses of 30 day potentially avoidable readmissions among patients with common comorbidities
Five most likely primary readmission diagnoses
Comorbidity FifthFourthThirdSecondFirst
Renal failure (2.7%; n=12)Gastrointestinal disorder
(3.9%; n=17)
Metabolic disorder (4.3%;
n=19)
Infection (12.9%; n=57)Neoplasm (16.3%; n=72)Neoplasm (n=441)
Liver disorder 4.2%; n=10)Ischemic heart disease
(4.7%; n=11)
Neoplasm (6.4%; n=15)Infection (8.9%; n=21)Heart failure (12.7%;
n=30)
Diabetes mellitus
(n=236)
Renal failure (2.9%; n=6)Arrhythmia (2.9%; n=6)Ischemic heart disease
(7.7%; n=16)
Infection (8.2%; n=17)Heart failure (26.1%;
n=54)
Chronic heart failure
(n=207)
Renal failure (3.4%; n=7)Arrhythmia (4.8%; n=10)Ischemic heart disease
(9.6%; n=20)
Infection (11.5%; n=24)Heart failure (13.5%;
n=28)
Ischemic heart disease
(n=208)
Gastrointestinal disorder
(3.8%; n=5)
Arrhythmia (8.3%; n=11)Ischemic heart disease
(8.3%; n=11)
Infection (11.4%; n=15)Heart failure (18.2%;
n=24)
Atrial fibrillation (n=132)
Venous thromboembolism
(3.5%; n=3)
COPD (5.8%; n=5)Neoplasm (9.3%; n=8)Heart failure (16.3%;
n=14)
Infection (16.3%; n=14)COPD (n=86)
Liver disorder (2.7%; n=5)Ischemic heart disease
(6.0%; n=11)
Renal failure (7.1%; n=13)Infection (8.2%; n=15)Heart failure (20.7%;
n=38)
Chronic kidney disease
(n=184)
Liver disorder (3.9%; n=33)Gastrointestinal disorder
(4.7%; n=40)
Heart failure (7.1%; n=61)Neoplasm (8.4%; n=72)Infection (11.6%; n=99)Entire cohort (n=854)
COPD=chronic obstructive pulmonary disease.
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Table 4| Relative risk of having 30 day potentially avoidable readmission versus no readmission for each comorbidity (n=9191)
Adjusted relative risk* (95% CI)Crude relative risk (95% CI)Comorbidity
1.83 (1.55 to 2.15)1.37 (1.26 to1.49)Neoplasm
1.16 (0.99 to 1.38)1.04 (0.99 to 1.09)Diabetes mellitus
1.23 (1.02 to 1.48)1.03 (0.99 to 1.08)Chronic heart failure
0.97 (0.81 to 1.17)0.96 (0.92 to 1.00)Ischemic heart disease
0.95 (0.77 to 1.17)0.97 (0.94 to 1.00)Atrial fibrillation
1.00 (0.80 to 1.27)0.99 (0.98 to 1.02)Chronic obstructive pulmonary disease
1.26 (1.04 to 1.52)1.06 (1.03 to 1.10)Chronic kidney disease
*From single logistic regression model with all comorbidities, adjusted for length of stay of index hospital admission, mode of admission (elective or not), number
of admissions in previous 12 months, number of procedures during index admission, and hemoglobin and sodium concentrations at discharge of index admission.
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Table 5| Relative risk of having avoidable versus unavoidable 30 day readmission for each comorbidity (n=2398)
Adjusted relative risk* (95% CI)Crude relative risk (95% CI)Comorbidity
0.97 (0.83 to 1.13)0.88 (0.80 to 0.96)Neoplasm
1.13 (0.98 to 1.30)1.29 (1.09 to 1.52)Diabetes mellitus
1.09 (0.92 to 1.29)1.34 (1.12 to 1.62)Chronic heart failure
0.99 (0.84 to 1.16)1.16 (0.98 to 1.38)Ischemic heart disease
1.03 (0.86 to 1.25)1.20 (0.95 to 1.52)Atrial fibrillation
1.02 (0.83 to 1.24)1.08 (0.83 to 1.42)Chronic obstructive pulmonary disease
1.18 (1.00 to 1.40)1.46 (1.19 to 1.79)Chronic kidney disease
*From single logistic regression model with all comorbidities, adjusted for length of stay of index hospital admission, mode of admission (elective or not), number
of admissions in previous 12 months, number of procedures during index admission, and hemoglobin and sodium concentrations at discharge of index admission.
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Figures
Fig 1 Flow chart of study
Fig 2 Match between primary diagnosis of index admission and 30 day potentially avoidable readmission among patients
readmitted for acute exacerbation of their comorbidity. Diabetes mellitus is not shown because MS-DRG codes do not
capture hyperglycemia specifically
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